Eyenovia, Inc. Announces Adjournment of 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format
June 11, 2020 16:10 ET
|
Eyenovia, Inc.
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
Eyenovia Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting Format
June 05, 2020 16:10 ET
|
Eyenovia, Inc.
NEW YORK, June 05, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Reports First Quarter 2020 Financial Results
May 13, 2020 16:05 ET
|
Eyenovia, Inc.
NEW YORK, May 13, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
Eyenovia Announces Conference Call and Webcast for First Quarter 2020 Financial Results
May 06, 2020 08:30 ET
|
Eyenovia, Inc.
NEW YORK, May 06, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
Eyenovia Reports Fourth Quarter and Full Year 2019 Financial Results
March 25, 2020 16:05 ET
|
Eyenovia, Inc.
NEW YORK, March 25, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private Placement
March 24, 2020 17:10 ET
|
Eyenovia, Inc.
NEW YORK, March 24, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ:EYEN) a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented...
Eyenovia, Inc. Announces Approximately $6.0 Million Private Placement
March 23, 2020 18:35 ET
|
Eyenovia, Inc.
NEW YORK, March 23, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Announces Conference Call and Webcast for Fourth Quarter and Full-Year 2019 Financial Results
March 11, 2020 08:30 ET
|
Eyenovia, Inc.
NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia to Participate in Two Upcoming Investor Conferences
March 04, 2020 08:30 ET
|
Eyenovia, Inc.
NEW YORK, March 04, 2020 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...
Eyenovia Expands Scientific Advisory Board with Two Experts in Optometry
December 19, 2019 08:30 ET
|
Eyenovia, Inc.
NEW YORK, Dec. 19, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its...